Skip to main content
News Tag: Newsletter
Advocate Angle: “Life’s a journey – travel well”
Read More
Advocate Angle: Improving the Cancer Clinical Trial Matching Ecosystem
Read More
FORTE Study Updates: November 2024
Read More
NRG-GU011 (“NRG PROMETHEAN”): stereotactic radiotherapy with or without relugolix for PET-recurrent oligometastatic prostate cancer
Read More
Moving anti-HER2 therapy into the peri-operative setting for locally advanced esophagogastric cancer
Read More
SBRT to the Primary Tumor Followed by Conventional Radiation Therapy and Chemotherapy for Patients with Locally Advanced Non-Small Cell Lung Cancer (NRG-LU008)
Read More
PSC Column: Optional Specimen Collection
Read More
FORTE Study Updates: October 2024
Read More
PSC Column: Understanding Consent Withdrawal: Guidelines for Patient Participation and Data Management
Read More
Advocate Angle: An Interview with Laurel Pracht: Making Strides to Fund the Future in Ovarian Cancer Research
Read More